TCRX · TScan Therapeutics, Inc. · Documents
$0.22
-0.01 (-2.28%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“However, substantial doubt about the Company's ability to continue as a going concern exists. ... These conditions raise substantial doubt about the Company's ability to continue as a going concern. ... Therefore, substantial doubt about the Company's ability to continue as a going concern has not been alleviated.”View the 10-Q filed Aug 12, 2026
Market Cap
$14.91M
Shares
67.78M
Volume · Oct 21
689.23K
Avg daily vol (3M)
771.87K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | TScan Therapeutics, Inc. reported that directors Garry Nicholson and Gabriela Gruia, M.D. resigned from its Board effective October 13, 2026, with no disagreement cited, and Stephen Biggar and R. Keith Woods were appointed to the Nominating and Corporate Governance Committee. | 2026-10-16 | 2026-10-13 | |
| PRE 14A | TScan Therapeutics is soliciting stockholder approval at a November 20, 2026 special meeting for a reverse stock split ranging from one-for-two to one-for-fifty to regain Nasdaq compliance following an August 27, 2026 deficiency letter; closing bid was $0.2379 on October 12, 2026. | 2026-10-16 | 2026-11-20 | |
| 8-K | — | 2026-09-30 | 2026-09-24 | |
| 8-K | — | 2026-09-11 | 2026-09-08 | |
| 8-K | — | 2026-09-02 | 2026-08-27 | |
| 8-K | — | 2026-08-18 | 2026-08-12 | |
| 10-Q | — | 2026-08-12 | 2026-06-30 | |
| 8-K | — | 2026-08-12 | — | |
| Investor Event Transcript | — | 2026-06-30 | — | |
| 8-K | — | 2026-06-22 | — | |
| 8-K | — | 2026-05-22 | 2026-05-20 | |
| 8-K | — | 2026-05-06 | — | |
| 10-Q | — | 2026-05-06 | 2026-03-31 | |
| ARS | — | 2026-04-17 | 2025-12-31 | |
| DEF 14A | — | 2026-04-17 | 2026-05-20 | |
| Investor Event Transcript | — | 2026-04-15 | 2026-06-30 | |
| PRE 14A | — | 2026-04-07 | 2026-05-20 | |
| 8-K | — | 2026-04-02 | 2026-03-31 | |
| 10-K | — | 2026-03-04 | 2025-12-31 | |
| 8-K | — | 2026-03-04 | — | |
| 8-K | — | 2026-01-12 | — | |
| 8-K | — | 2025-11-26 | 2025-11-25 | |
| 10-Q | — | 2025-11-12 | 2025-09-30 | |
| 8-K | — | 2025-11-12 | — | |
| 8-K | — | 2025-11-03 | — | |
| 8-K | — | 2025-09-09 | — | |
| 8-K | — | 2025-08-20 | 2025-08-14 | |
| 10-Q | — | 2025-08-12 | 2025-06-30 | |
| 8-K | — | 2025-08-12 | — | |
| 8-K | — | 2025-07-02 | 2025-06-30 | |
| DEF 14A | — | 2025-05-14 | 2025-06-30 | |
| ARS | — | 2025-05-14 | 2024-12-31 | |
| DEFA14A | — | 2025-05-14 | — | |
| 10-Q | — | 2025-05-06 | 2025-03-31 | |
| 8-K | — | 2025-05-06 | — | |
| 10-K | — | 2025-03-05 | 2024-12-31 | |
| S-3 | — | 2025-03-05 | — | |
| 8-K | — | 2025-03-05 | — | |
| 8-K | — | 2024-12-26 | — | |
| 8-K | — | 2024-12-23 | 2024-12-20 | |
| 8-K | — | 2024-12-10 | 2024-12-09 | |
| 8-K | — | 2024-11-21 | 2024-11-15 | |
| 10-Q | — | 2024-11-12 | 2024-09-30 | |
| 8-K | — | 2024-11-12 | — | |
| 8-K | — | 2024-11-01 | 2024-10-28 | |
| 8-K | — | 2024-08-12 | — | |
| 10-Q | — | 2024-08-12 | 2024-06-30 | |
| 8-K | — | 2024-06-14 | 2024-06-12 | |
| 10-Q | — | 2024-05-13 | 2024-03-31 | |
| 8-K | — | 2024-05-13 | — |
Showing 1–50 of 117 filings